Standardization of reduced and optimal lead sets for continuous electrocardiogram monitoring: where do we stand?

B Drew, D Finlay

Research output: Contribution to journalArticle

12 Citations (Scopus)

Abstract

Mason-Likar or proprietary reduced lead (RL) configurations are used for continuous 12-lead electrocardiogram (ECG) monitoring. Because each RL set has a different electrode configuration and derivation, they are inherently different and should not be compared with each other or with the Mason-Likar or standard ECG to determine changes in an individual over time. Recently, cases have been reported regarding misdiagnosis resulting from such invalid comparisons. This article addresses several relevant questions and presents data collected from 559 subjects (one third, prior myocardial infarction; one third, left ventricular hypertrophy; one third, healthy controls) comparing standard limb leads with body surface potential map (BSPM) leads. We conclude the following: (1) There are few circumstances that justify the use of RL 12-lead ECGs; the convenience should be weighed by the risk of misdiagnosis resulting from serial comparison of nonequivalent ECGs. (2) When RL monitoring is justified, standardization of one universally adopted method would reduce confusion about multiple proprietary lead configurations and minimize invalid ECG comparisons in individuals treated in multiple hospital units with different manufacturers cardiac monitors. (3) Standard limb lead P-QRS-T waveforms correlate highly with BSPM leads located outside standard unipolar precordial lead sites. Until it is clear that “optimum” BSPM lead sites do not overlap with ECG information already contributed from standard limb leads, it is premature to recommend alternative lead sites for ECG monitoring.
LanguageEnglish
Pages458-465
JournalJournal of Electrocardiology
Volume41
Issue number6
DOIs
Publication statusPublished - Nov 2008

Fingerprint

Electrocardiography
Extremities
Diagnostic Errors
Lead
Hospital Units
Left Ventricular Hypertrophy
Electrodes
Myocardial Infarction

Cite this

@article{72b4d29c671d4d37b77b4430e3e21b9c,
title = "Standardization of reduced and optimal lead sets for continuous electrocardiogram monitoring: where do we stand?",
abstract = "Mason-Likar or proprietary reduced lead (RL) configurations are used for continuous 12-lead electrocardiogram (ECG) monitoring. Because each RL set has a different electrode configuration and derivation, they are inherently different and should not be compared with each other or with the Mason-Likar or standard ECG to determine changes in an individual over time. Recently, cases have been reported regarding misdiagnosis resulting from such invalid comparisons. This article addresses several relevant questions and presents data collected from 559 subjects (one third, prior myocardial infarction; one third, left ventricular hypertrophy; one third, healthy controls) comparing standard limb leads with body surface potential map (BSPM) leads. We conclude the following: (1) There are few circumstances that justify the use of RL 12-lead ECGs; the convenience should be weighed by the risk of misdiagnosis resulting from serial comparison of nonequivalent ECGs. (2) When RL monitoring is justified, standardization of one universally adopted method would reduce confusion about multiple proprietary lead configurations and minimize invalid ECG comparisons in individuals treated in multiple hospital units with different manufacturers cardiac monitors. (3) Standard limb lead P-QRS-T waveforms correlate highly with BSPM leads located outside standard unipolar precordial lead sites. Until it is clear that “optimum” BSPM lead sites do not overlap with ECG information already contributed from standard limb leads, it is premature to recommend alternative lead sites for ECG monitoring.",
author = "B Drew and D Finlay",
year = "2008",
month = "11",
doi = "10.1016/j.jelectrocard.2008.06.012",
language = "English",
volume = "41",
pages = "458--465",
journal = "Journal of Electrocardiology",
issn = "0022-0736",
publisher = "Elsevier",
number = "6",

}

Standardization of reduced and optimal lead sets for continuous electrocardiogram monitoring: where do we stand? / Drew, B; Finlay, D.

In: Journal of Electrocardiology, Vol. 41, No. 6, 11.2008, p. 458-465.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Standardization of reduced and optimal lead sets for continuous electrocardiogram monitoring: where do we stand?

AU - Drew, B

AU - Finlay, D

PY - 2008/11

Y1 - 2008/11

N2 - Mason-Likar or proprietary reduced lead (RL) configurations are used for continuous 12-lead electrocardiogram (ECG) monitoring. Because each RL set has a different electrode configuration and derivation, they are inherently different and should not be compared with each other or with the Mason-Likar or standard ECG to determine changes in an individual over time. Recently, cases have been reported regarding misdiagnosis resulting from such invalid comparisons. This article addresses several relevant questions and presents data collected from 559 subjects (one third, prior myocardial infarction; one third, left ventricular hypertrophy; one third, healthy controls) comparing standard limb leads with body surface potential map (BSPM) leads. We conclude the following: (1) There are few circumstances that justify the use of RL 12-lead ECGs; the convenience should be weighed by the risk of misdiagnosis resulting from serial comparison of nonequivalent ECGs. (2) When RL monitoring is justified, standardization of one universally adopted method would reduce confusion about multiple proprietary lead configurations and minimize invalid ECG comparisons in individuals treated in multiple hospital units with different manufacturers cardiac monitors. (3) Standard limb lead P-QRS-T waveforms correlate highly with BSPM leads located outside standard unipolar precordial lead sites. Until it is clear that “optimum” BSPM lead sites do not overlap with ECG information already contributed from standard limb leads, it is premature to recommend alternative lead sites for ECG monitoring.

AB - Mason-Likar or proprietary reduced lead (RL) configurations are used for continuous 12-lead electrocardiogram (ECG) monitoring. Because each RL set has a different electrode configuration and derivation, they are inherently different and should not be compared with each other or with the Mason-Likar or standard ECG to determine changes in an individual over time. Recently, cases have been reported regarding misdiagnosis resulting from such invalid comparisons. This article addresses several relevant questions and presents data collected from 559 subjects (one third, prior myocardial infarction; one third, left ventricular hypertrophy; one third, healthy controls) comparing standard limb leads with body surface potential map (BSPM) leads. We conclude the following: (1) There are few circumstances that justify the use of RL 12-lead ECGs; the convenience should be weighed by the risk of misdiagnosis resulting from serial comparison of nonequivalent ECGs. (2) When RL monitoring is justified, standardization of one universally adopted method would reduce confusion about multiple proprietary lead configurations and minimize invalid ECG comparisons in individuals treated in multiple hospital units with different manufacturers cardiac monitors. (3) Standard limb lead P-QRS-T waveforms correlate highly with BSPM leads located outside standard unipolar precordial lead sites. Until it is clear that “optimum” BSPM lead sites do not overlap with ECG information already contributed from standard limb leads, it is premature to recommend alternative lead sites for ECG monitoring.

U2 - 10.1016/j.jelectrocard.2008.06.012

DO - 10.1016/j.jelectrocard.2008.06.012

M3 - Article

VL - 41

SP - 458

EP - 465

JO - Journal of Electrocardiology

T2 - Journal of Electrocardiology

JF - Journal of Electrocardiology

SN - 0022-0736

IS - 6

ER -